Related Experiment Video
Updated: May 28, 2026

Spatial and Temporal Analysis of Active ERK in the C. elegans Germline
Published on: November 29, 2016
MEK5/ERK5 pathway: the first fifteen years
Barbara A Drew1, Matthew E Burow, Barbara S Beckman
1Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Abstract:
While conventional MAP kinase pathways are one of the most highly studied signal transduction molecules, less is known about the MEK5 signaling pathway. This pathway has been shown to play a role in normal cell growth cycles, survival and differentiation. The MEK5 pathway is also believed to mediate the effects of a number of oncogenes. MEK5 is the upstream activator of ERK5 in many epithelial cells. Activation of the MEK-MAPK pathway is a frequent event in malignant tumor formation and contributes to chemoresistance and anti-apoptotic signaling. This pathway may be involved in a number of more aggressive, metastatic varieties of cancer due to its role in cell survival, proliferation and EMT transitioning. Further study of this pathway may lead to new prognostic factors and new drug targets to combat more aggressive forms of cancer.
Insights
The MEK5-ERK5 pathway regulates cell growth and survival, potentially driving aggressive cancers. Understanding this signaling pathway could reveal new drug targets for cancer treatment.
Area of Science:
- Cellular signaling pathways
- Molecular biology
- Cancer research
Background:
- Conventional MAP kinase pathways are well-studied, but the MEK5 signaling pathway's role is less understood.
- The MEK5 pathway influences cell growth, survival, and differentiation, and is implicated in oncogene activity.
Purpose of the Study:
- To explore the significance of the MEK5-ERK5 signaling pathway in cellular processes.
- To investigate the MEK5 pathway's involvement in cancer development and progression.
Main Methods:
- The study focuses on the known molecular interactions and biological roles of the MEK5-ERK5 pathway.
- Literature review and analysis of existing research on MEK5 and ERK5 signaling in cancer.
Main Results:
- MEK5 activates ERK5, a key event in epithelial cells.
- Activation of the MEK-MAPK pathway, including MEK5-ERK5, is common in tumors, promoting survival and chemoresistance.
Conclusions:
- The MEK5-ERK5 pathway may contribute to aggressive and metastatic cancers through its role in cell survival, proliferation, and epithelial-mesenchymal transition (EMT).
- Further research into this pathway could identify novel prognostic markers and therapeutic targets for advanced cancers.
More Related Videos
07:55Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment
Published on: September 25, 2017
09:32Light-mediated Reversible Modulation of the Mitogen-activated Protein Kinase Pathway during Cell Differentiation and Xenopus Embryonic Development
Published on: June 15, 2017
Related Concept Videos
MAPK Signaling Cascades
Amplifying Signals via Enzymatic Cascade
ER Retrieval Pathway
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Other Glycolytic Pathways
cAMP-dependent Protein Kinase Pathways